Lindbrook Capital’s AtriCure ATRC Stock Holding History

Lindbrook Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$4.94K	Buy	153 +20	+15%	+$742	﹤0.01%	1959
2024 Q4	$4.06K	Hold	133	–	–	﹤0.01%	2080
2024 Q3	$3.73K	Sell	133 -258	-66%	-$6.36K	﹤0.01%	2132
2024 Q2	$8.9K	Buy	+391	New	+$9.02K	﹤0.01%	1689
2024 Q1	–	Sell	-30	Closed	-$1.07K	–	2649
2023 Q4	$1.07K	Buy	+30	New	+$1.12K	﹤0.01%	2452
2023 Q3	–	Sell	-12	Closed	-$592	–	2692
2023 Q2	$592	Hold	12	–	–	﹤0.01%	2473
2023 Q1	$497	Buy	+12	New	+$498	﹤0.01%	2608
2022 Q4	–	Sell	-391	Closed	-$15K	–	2836
2022 Q3	$15K	Sell	391 -159	-29%	-$7.27K	﹤0.01%	1121
2022 Q2	$22K	Sell	550 -630	-53%	-$29.8K	﹤0.01%	926
2022 Q1	$77K	Sell	1,180 -1,242	-51%	-$80.5K	0.01%	549
2021 Q4	$168K	Buy	+2,422	New	+$176K	0.03%	345

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Lindbrook Capital's ATRC Position: Q1 2025 in Review

Lindbrook Capital increased its AtriCure (ATRC) stake by 15% in Q1 2025, buying an estimated $742 and bringing the position to 153 shares worth $4.94K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.

Lindbrook Capital first reported a position in ATRC in Q4 2021 and has held it in 11 quarters since. The position peaked at $168K in Q4 2021. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.

Lindbrook Capital held 153 shares of AtriCure worth $4.94K as of Q1 2025.
Lindbrook Capital bought 20 AtriCure shares in Q1 2025, an estimated $742.
AtriCure made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1959 holding.
Lindbrook Capital first reported a position in AtriCure in Q4 2021 and has held it in 11 quarters since.
Lindbrook Capital's AtriCure position peaked at $168K in Q4 2021.
221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.